ICU SeaStar Medical Holding Corporation
Company Analysis
Latest News
π’ SeaStar Medical is trading 6.2% up today with broader healthcare strength a possible factor
SeaStar Medical is trading at $3.08, up 6.20% in live trading, with no clear company-specific catalyst identified for the October 19 move. - The latest...
π΄ SeaStar Medical is trading 5% down today amid market weakness; no direct catalyst confirmed
SeaStar Medical is trading at $2.90, down 5.23%, with broad market weakness the likeliest available context, not a confirmed catalyst. - Current coverage...
π΄ SeaStar Medical is trading 10.72% down on October 14, 2026 with no confirmed company-specific catalyst
SeaStar Medical is trading at $3.21, down 10.72%, with no confirmed company-specific catalyst explaining the decline. - The October 14 announcement concerned...
π΄ SeaStar Medical is trading 6.4% down
SeaStar Medical is trading 6.4% lower at $3.36, with no identified company-specific announcement or confirmed catalyst explaining the October 14, 2026...
π΄ SeaStar Medical is trading 5.3% down in pre-market with no clear catalyst identified
SeaStar Medical is trading 5.3% lower at $3.40 in pre-market, with no direct company or market catalyst established. - Shares declined 6.75% to $3.59 on...
π΄ SeaStar Medical is trading 8.1% down today β no clear catalyst identified
SeaStar Medical is trading 8.1% lower at $3.54, with no clear company-specific announcement identified to explain the October 13 move. - The broader market...
π’ SeaStar Medical is trading 5.8% up today with no confirmed catalyst
SeaStar Medical is trading up 5.82% at $3.82, with no confirmed catalyst identified for the October 12, 2026 move. - The latest notable company news was the...
π’ SeaStar Medical is trading 5.73% up in pre-market with no confirmed catalyst
SeaStar Medical is trading at $3.69, up 5.73% in pre-market; no confirmed catalyst for October 9 was identified. - The latest major company news was the FDAβs...
π΄ SeaStar Medical is trading 7.77% down with no explanation identified
SeaStar Medical is trading 7.77% lower at $3.43, with no new company announcement identified to explain the decline. - On October 7, shares gained 16.61% to...
π΄ SeaStar Medical is trading 9.1% down in pre-market
SeaStar Medical is trading 9.13% down at $3.38 in pre-market on October 8; no new company announcement explaining the decline was found. - The FDA granted its...
π’ SeaStar Medical is trading 11% up today after FDA grants SCD Breakthrough Device Designation
SeaStar Medical is trading 10.97% higher at $3.54, with the FDA designation a possible catalyst. - On October 7, 2026, the FDA granted Breakthrough Device...
π’ SeaStar Medical is trading 6.3% up today β with no clear company-specific catalyst
SeaStar Medical is trading at $3.39, up 6.26%, with no clear company-specific announcement explaining the October 7 gain. - The latest notable company news...
π΄ SeaStar Medical is trading 12.3% down today after warrant deal added potential dilution
SeaStar Medical is trading 12.3% down at $3.11, continuing its decline after the October 5 warrant deal raised potential dilution concerns. - The company...
SeaStar Medical's $3.3 Million Warrant Deal Stops the Bleeding on Cash but Opens the Vein on Dilution β Can the Stock Recover?
Shares of SeaStar Medical cratered 23% to $3.61 on October 5 after the micro-cap medical device company announced a discounted warrant exercise that hands...
π΄ SeaStar Medical is trading 23% down today; discounted warrant deal is a possible catalyst
SeaStar Medical is trading 23.03% down at $3.61; its warrant deal is a possible, unconfirmed catalyst. - On October 5, investors agreed to exercise warrants...
π΄ SeaStar Medical is trading 21.11% down in pre-market with no confirmed catalyst
SeaStar Medical is trading at $3.70, down 21.11%, with no verified explanation for the pre-market decline. - Shares fell from the October 2 close of $4.69;...
π’ SeaStar Medical is trading 10.45% up in pre-market amid new inpatient billing codes for SCD therapy
SeaStar Medical is trading at $5.18, up 10.45% in pre-market, amid the availability of new ICD-10-PCS codes for its SCD therapy; available reporting does not...
π’ SeaStar Medical is trading 6.2% up in pre-market amid new SCD therapy billing codes
SeaStar Medical is trading at $4.98, up 6.18%, amid new SCD therapy billing codes, the clearest company-specific context; no source explicitly linked them to...
SeaStar Medical Secures New ICD-10-PCS Codes for SCD Therapy
As of October 1, 2026, new ICD-10-PCS codes are available for SeaStar Medical Holding Corporationβs Selective Cytopheretic Device (SCD) therapy. [3, 6] The...
π’ SeaStar Medical is trading 12% up today as jobs data eased rate-hike concerns
SeaStar Medical is trading at $4.21, up 12.24%, alongside a broader market rally as investors interpreted September jobs data as easing pressure for further...